Profit Or Loss [Abstract]

Sopharma Trading AD - Filing #6022492

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Raw materials and consumables used
9,042,000.000 BGN
6,863,000.000 BGN
Employee benefits expense
80,841,000.000 BGN
57,303,000.000 BGN
Depreciation and amortisation expense
28,554,000.000 BGN
20,040,000.000 BGN
Other expenses, by nature
10,183,000.000 BGN
4,808,000.000 BGN
Profit (loss) from operating activities
13,820,000.000 BGN
17,742,000.000 BGN
Finance income
2,106,000.000 BGN
1,671,000.000 BGN
Finance costs
6,489,000.000 BGN
5,491,000.000 BGN
Profit (loss) before tax
9,437,000.000 BGN
13,922,000.000 BGN
Tax expense (income)
1,387,000.000 BGN
2,446,000.000 BGN
Profit (loss)
- BGN
- BGN
- BGN
- BGN
- BGN
8,050,000.000 BGN
8,050,000.000 BGN
11,476,000.000 BGN
- BGN
11,476,000.000 BGN
- BGN
- BGN
- BGN
- BGN
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
0.23
0.33

Talk to a Data Expert

Have a question? We'll get back to you promptly.